Conjugative CRISPR System Cuts Resistance
-
By
February 13, 2026
-
4 min
A proof-of-principle study published in npj Antimicrobials and Resistance explored a gene drive-like system using a 65-kilobase plasmid, pPro-MobV, to effectively combat antibiotic resistance in bacteria. Researchers demonstrated that this plasmid allows efficient horizontal transfer of an anti-antibiotic resistance cassette, significantly reducing ampicillin-resistant colony-forming units in various strains while showing enhanced effects in RecA-deficient strains. This strategy may lead to advanced methodologies in microbiome engineering and address challenges like antibiotic resistance.
1. Engineered pPro-MobV plasmid targets antibiotic resistance.2. Horizontal gene transfer demonstrated with a frequency of ~40%.3. RecA-deficient strains showed enhanced effects.4. Insertional inactivation more effective than plasmid elimination.5. Study highlights implications for microbiome engineering and ecological health.
Listen Tab content